Menu Search
Equities

Sisram Medical Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
1696:HKG.HZ

Sisram Medical Ltd

Actions
  • Price (HKD)4.03
  • Today's Change0.00 / 0.00%
  • Shares traded23.60k
  • 1 Year change+11.94%
  • Beta1.5102
Data delayed at least 15 minutes, as of Feb 16 2026 03:50 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sisram Medical Ltd. is an Israel-based company primarily engaged in the medical aesthetics industry. The Company focuses on developing and manufacturing natural energy-based medical aesthetic devices and dental equipment. The Company operates several brands among which are Alma, LMNT, Copulla. Alma is provider of energy-based solutions for surgical, medical aesthetics, and beauty markets. It offers a range of products for hair removal, skin rejuvenation, acne treatment, body and face contouring, and more; LMNT, a personal care brand that delivers wellness into daily routines. It focuses on providing consumers with special purpose technology for personal care; Copulla, which offers an end-to-end digital dentistry service that aims to streamline the dental workflow and to cover all aspects from intra-oral scanning to the final delivery of dental appliances.

  • Revenue in HKD (TTM)2.70bn
  • Net income in HKD160.99m
  • Incorporated2013
  • Employees1.04k
  • Location
    Sisram Medical LtdOFEK 15 Building18 HaHarash Street, Industrial ParkCAESAREA 3079895IsraelISR
  • Phone+972 46275357
  • Websitehttps://sisram-medical.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.